Literature DB >> 24222943

Quasispecies structure, cornerstone of hepatitis B virus infection: mass sequencing approach.

Francisco Rodriguez-Frias1, Maria Buti, David Tabernero, Maria Homs.   

Abstract

Hepatitis B virus (HBV) is a DNA virus with complex replication, and high replication and mutation rates, leading to a heterogeneous viral population. The population is comprised of genomes that are closely related, but not identical; hence, HBV is considered a viral quasispecies. Quasispecies variability may be somewhat limited by the high degree of overlapping between the HBV coding regions, which is especially important in the P and S gene overlapping regions, but is less significant in the X and preCore/Core genes. Despite this restriction, several clinically and pathologically relevant variants have been characterized along the viral genome. Next-generation sequencing (NGS) approaches enable high-throughput analysis of thousands of clonally amplified regions and are powerful tools for characterizing genetic diversity in viral strains. In the present review, we update the information regarding HBV variability and present a summary of the various NGS approaches available for research in this virus. In addition, we provide an analysis of the clinical implications of HBV variants and their study by NGS.

Entities:  

Keywords:  Gene overlapping; Hepatitis B virus; Linkage analysis; Next generation sequencing; Quasispecies

Mesh:

Substances:

Year:  2013        PMID: 24222943      PMCID: PMC3819535          DOI: 10.3748/wjg.v19.i41.6995

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  258 in total

Review 1.  Hepatitis B e antigen-negative chronic hepatitis B.

Authors:  S J Hadziyannis; D Vassilopoulos
Journal:  Hepatology       Date:  2001-10       Impact factor: 17.425

2.  Hepatitis B virus harboring nucleotide deletions in the core promoter region and genotype B correlate with low viral replication activity in anti-HBe positive carriers.

Authors:  K S Li; T Yamashiro; A Sumie; H Terao; K Mifune; A Nishizono
Journal:  J Clin Virol       Date:  2001-12       Impact factor: 3.168

Review 3.  The core promoter of hepatitis B virus.

Authors:  A Kramvis; M C Kew
Journal:  J Viral Hepat       Date:  1999-11       Impact factor: 3.728

4.  Comparison study on the complete sequence of hepatitis B virus identifies new mutations in core gene associated with hepatocellular carcinoma.

Authors:  Yu Zhu; Yan Jin; Xia Guo; Xin Bai; Taoyang Chen; Jinbing Wang; Gengsun Qian; John D Groopman; Jianren Gu; Jinjun Li; Hong Tu
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-08-10       Impact factor: 4.254

5.  Reduced precore transcription and enhanced core-pregenome transcription of hepatitis B virus DNA after replacement of the precore-core promoter with sequences associated with e antigen-seronegative persistent infections.

Authors:  K Moriyama; H Okamoto; F Tsuda; M Mayumi
Journal:  Virology       Date:  1996-12-15       Impact factor: 3.616

6.  A novel mutation pattern emerging during lamivudine treatment shows cross-resistance to adefovir dipivoxil treatment.

Authors:  Ersin Karatayli; Selim Karayalçin; Hayri Karaaslan; Handan Kayhan; A Resat Türkyilmaz; Fikret Sahin; Cihan Yurdaydin; A Mithat Bozdayi
Journal:  Antivir Ther       Date:  2007

Review 7.  Clinical significance of hepatitis B virus genotypes, variants, and mutants.

Authors:  Chun-Tao Wai; Robert J Fontana
Journal:  Clin Liver Dis       Date:  2004-05       Impact factor: 6.126

8.  In vitro resistance to interferon-alpha of hepatitis B virus with basic core promoter double mutation.

Authors:  Yan Wang; Lai Wei; Dong Jiang; Xu Cong; Ran Fei; Hongsong Chen; Jiang Xiao; Yu Wang
Journal:  Antiviral Res       Date:  2007-03-08       Impact factor: 5.970

9.  Carboxyl-terminal truncated HBx regulates a distinct microRNA transcription program in hepatocellular carcinoma development.

Authors:  Wing-Kit Yip; Alfred Sze-Lok Cheng; Ranxu Zhu; Raymond Wai-Ming Lung; Daisy Pui-Fong Tsang; Suki Shuk-Kei Lau; Yangchao Chen; Jonathan Gabriel Sung; Paul Bo-San Lai; Enders Kai-On Ng; Jun Yu; Nathalie Wong; Ka-Fai To; Vincent Wai-Sun Wong; Joseph Jao-Yiu Sung; Henry Lik-Yuen Chan
Journal:  PLoS One       Date:  2011-08-04       Impact factor: 3.240

10.  Naturally occurring precore/core region mutations of hepatitis B virus genotype C related to hepatocellular carcinoma.

Authors:  Dong-Won Kim; Seoung-Ae Lee; Eung-Soo Hwang; Yoon-Hoh Kook; Bum-Joon Kim
Journal:  PLoS One       Date:  2012-10-10       Impact factor: 3.240

View more
  18 in total

Review 1.  Genotypes and viral variants in chronic hepatitis B: A review of epidemiology and clinical relevance.

Authors:  Catherine Mn Croagh; Paul V Desmond; Sally J Bell
Journal:  World J Hepatol       Date:  2015-03-27

2.  Combined viral quasispecies diversity and hepatitis B core-related antigen predict off-nucleos(t)ide analog durability in HBeAg-negative patients.

Authors:  Huei-Ru Cheng; Hung-Chih Yang; Su-Ru Lin; Ta-Yu Yang; You-Yu Lin; Tung-Hung Su; Tai-Chung Tseng; Chun-Jen Liu; Jia-Horng Kao
Journal:  Hepatol Int       Date:  2021-04-22       Impact factor: 6.047

3.  Ultradeep Sequencing for Detection of Quasispecies Variants in the Major Hydrophilic Region of Hepatitis B Virus in Indonesian Patients.

Authors:  Laura Navika Yamani; Yoshihiko Yano; Takako Utsumi; Hadi Wandono; Doddy Widjanarko; Ari Triantanoe; Widya Wasityastuti; Yujiao Liang; Rina Okada; Toshihito Tanahashi; Yoshiki Murakami; Takeshi Azuma; Maria Inge Lusida; Yoshitake Hayashi
Journal:  J Clin Microbiol       Date:  2015-07-22       Impact factor: 5.948

4.  Hepatitis B Virus Variants with Multiple Insertions and/or Deletions in the X Open Reading Frame 3' End: Common Members of Viral Quasispecies in Chronic Hepatitis B Patients.

Authors:  Selene García-García; Andrea Caballero-Garralda; David Tabernero; Maria Francesca Cortese; Josep Gregori; Francisco Rodriguez-Algarra; Josep Quer; Mar Riveiro-Barciela; Maria Homs; Ariadna Rando-Segura; Beatriz Pacin-Ruiz; Marta Vila; Roser Ferrer-Costa; Tomas Pumarola; Maria Buti; Francisco Rodriguez-Frias
Journal:  Biomedicines       Date:  2022-05-21

Review 5.  Update on hepatitis B and C virus diagnosis.

Authors:  Livia Melo Villar; Helena Medina Cruz; Jakeline Ribeiro Barbosa; Cristianne Sousa Bezerra; Moyra Machado Portilho; Letícia de Paula Scalioni
Journal:  World J Virol       Date:  2015-11-12

6.  Single-Molecule Sequencing Reveals Complex Genome Variation of Hepatitis B Virus during 15 Years of Chronic Infection following Liver Transplantation.

Authors:  B D Betz-Stablein; A Töpfer; M Littlejohn; L Yuen; D Colledge; V Sozzi; P Angus; A Thompson; P Revill; N Beerenwinkel; N Warner; F Luciani
Journal:  J Virol       Date:  2016-07-27       Impact factor: 5.103

7.  Clinical application of estimating hepatitis B virus quasispecies complexity by massive sequencing: correlation between natural evolution and on-treatment evolution.

Authors:  Maria Homs; Andrea Caballero; Josep Gregori; David Tabernero; Josep Quer; Leonardo Nieto; Rafael Esteban; Maria Buti; Francisco Rodriguez-Frias
Journal:  PLoS One       Date:  2014-11-13       Impact factor: 3.240

8.  Evaluation of the G145R Mutant of the Hepatitis B Virus as a Minor Strain in Mother-to-Child Transmission.

Authors:  Haruki Komatsu; Ayano Inui; Shuichiro Umetsu; Tomoyuki Tsunoda; Tsuyoshi Sogo; Yasuhiro Konishi; Tomoo Fujisawa
Journal:  PLoS One       Date:  2016-11-03       Impact factor: 3.240

9.  Accurate assembly of minority viral haplotypes from next-generation sequencing through efficient noise reduction.

Authors:  Sergey Knyazev; Viachaslau Tsyvina; Anupama Shankar; Andrew Melnyk; Alexander Artyomenko; Tatiana Malygina; Yuri B Porozov; Ellsworth M Campbell; William M Switzer; Pavel Skums; Serghei Mangul; Alex Zelikovsky
Journal:  Nucleic Acids Res       Date:  2021-09-27       Impact factor: 16.971

10.  Evaluation of the dynamic pattern of viral evolution in patients with virological breakthrough during treatment with nucleoside/nucleotide analogs by ultra‑deep pyrosequencing.

Authors:  Shaolong Chen; Jing Wu; Erli Gu; Yaojie Shen; Feifei Wang; Wenhong Zhang
Journal:  Mol Med Rep       Date:  2015-11-19       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.